Brenus Pharma Company

Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance.
Technology: Atrificial Vectors and Immune Cells
Headquarters: Issoire, Auvergne, France
Founded Date: 2014-01-01
Employees Number: 1-10
Funding Status: Seed
Investors Number: 3
Total Funding: 99300000
Last Funding Date: 2022-03-17
Last Funding Type: Seed

Visit Website
contact@brenus-pharma.com
https://twitter.com/BrenusP
Register and Claim Ownership